Clinical Trials Search
Clinical Trial 19320
Cancer Type: Thoracic
Study Type: Treatment
Phase of Study: NA
An Open-Label, Multicenter Extension Study In Patients Previously Enrolled In A Genentech and/or F Hoffmann La Roche Ltd. Sponsored Atezolizumab Study
The purpose of this study is to find out what effects, good or bad, atezolizumab alone or atezolizumab combined with other agent(s) or comparator agent(s) have on participants and their cancer and to provide continued access to atezolizumab-based therapy and/or comparator agent(s) for eligible participants who were previously enrolled and treated in a parent study.
To provide continued access to atezolizumab-based therapy and/or comparator agent(s) for eligible patients still on study treatment at the time of the parent-study closure